Researchers at UCLA have developed a once-daily pill that targets a protein crucial to pancreatic cancer growth, offering new hope for one of the deadliest cancers.
The breakthrough treatment represents a major step forward in fighting a disease that has long resisted effective therapies.
Want to know more?